Patients with stage @ CKD ( estimated glomerular filtration rate -LSB- eGFR -RSB- @ to < @ mL/min per @ m ( @ ) ; n = @ ) were randomly assigned ( @:@:@ ) to receive empagliflozin @ mg or @ mg or placebo once daily for @ weeks .